Related to FDA Clears Avid’s Amyloid Plaque Imaging Agent for Aiding Alzheimer Disease Diagnosis

• Readers Show Confidence in FDA’s Biosimilar User Fee Framework
  
• Roche Gets CE Clearance for Two HCV Molecular Diagnostics
  
• Qiagen Signs Two Biomarker Deals and Confirms Japanese Okay for EGFR Companion Dx
  
• FDA Clears BTG’s Voraxaze for Treating Methotrexate Toxicity
  
• Gilead Wins Sanction in the U.S. for Viread in HIV-Infected Children
  
• FDA Asks BMS, AstraZeneca for More Clinical Data for Antidiabetic
  
• FDA Clears Subcutaneous Velcade for All Approved Indications
  
• FDA Clears Leo’s Picato Gel for 2–3 Day Treatment of Actinic Keratosis
  
• FDA Clears Roche’s Erivedge for Treating Advanced Basal Cell Carcinoma
  
• Pfizer’s Inlyta Approved in U.S. as Therapy for Advanced Renal Cell Carcinoma
  
• FDA Sanctions Vertex’ Kalydeco for Treating Cystic Fibrosis Caused by G551D Mutations
  
• FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery
  
• Roche’s Cobas Test for Chlamydia and Gonorrhea Granted 510(k) Clearance in U.S.
  
• FDA Okays Shire's ADHD Drug Vyvanse for Maintenance Therapy in Adults
  
• FDA Issues Draft Guidance for Getting Biosimilars Approved
  
• BioSante, Teva Win FDA Nod for Male Hypogonadism Therapy
  
• EC Grants CE Mark for Trinity’s Point-of-Care Test for Giardiasis
  
• FDA Clears MedImmune’s FluMist Quadrivalent Flu Vaccine
  
• FDA Clears Discovery Laboratories’ Drug for Respiratory Distress Syndrome in Infants
  
• RNA Spinach Sensor Tracks Metabolites Not Amenable to Fluorescent Protein Tags